Levine, you will have the opportunity to discuss your health concerns, goals, and preferences
The IR, IGF-1R and their hybrid receptors are expressed by most human tumors, whereby predominant expression of the IR-A isoform correlates with a poor differentiation grade

Common GI side effects (affecting more than 1 in 10 people) according to the SmPC: Nausea : The most frequent side effect, reported in approximately 44% of patients in clinical trials, usually most pronounced during the first few weeks and with dose increases Diarrhoea : Affects roughly 30% of users, typically mild to moderate and transient Vomiting : Occurs in about 24% of patients, often associated with eating too quickly or consuming large portions Constipation : Reported in approximately 24% of users, which may require dietary modification or occasional laxative use Abdominal pain or discomfort : Affects around 20% of patients, usually described as cramping or bloating Dyspepsia and reflux : Indigestion and heartburn occur in approximately 9% of users Less common but significant GI effects : Delayed gastric emptying : Whilst this is the intended pharmacological effect, in some cases it can cause persistent nausea, vomiting, and inability to tolerate food Pancreatitis : Has been reported in clinical trials and post-marketing

5 (6): 61632 Pescosolido N, Giorgini S, Scarsella G, et al
The HealthRX.com Drug-Cramp Interaction Checklist A structured approach to evaluating medication-related cramp risk in GLP-1 patients prevents overlooked interactions
Dose calculations at 5,000 mcg/mL: 1mg dose = 0.2mL = 20 units on U-100 syringe 2mg dose = 0.4mL = 40 units 4mg dose = 0.8mL = 80 units 6mg dose = 1.2mL = 120 units 8mg dose = 1.6mL = 160 units 12mg dose = 2.4mL = 240 units This dilution makes higher doses more practical within a single syringe for mid-range protocols